2015 Press Releases

2015 | 2014 | 2013
Keyword Search
 
DateTitle 
05/26/15Depomed To Present At Healthcare Conferences In JunePrinter Friendly Version
05/13/15Depomed To Present At Healthcare Conferences In MayPrinter Friendly Version
05/11/15Depomed Reports First Quarter 2015 Financial ResultsPrinter Friendly Version
04/30/15Depomed to Report First Quarter Fiscal Year 2015 Financial Results on Monday, May 11, 2015Printer Friendly Version
04/13/15Depomed Announces Gralise® ANDA Litigation Settlement Confirming Exclusivity to 2024 and Dismissing AppealPrinter Friendly Version
04/02/15Depomed Announces Closing of Acquisition of U.S. Rights to NUCYNTA® (tapentadol), NUCYNTA® ER (tapentadol) extended release tablets and NUCYNTA® (tapentadol) oral solution from Janssen Pharmaceuticals, Inc. for $1.05 billionPrinter Friendly Version
03/17/15Depomed Announces Termination of Hart-Scott-Rodino Waiting Period for Pending Acquisition of NUCYNTA® Franchise from Janssen PharmaceuticalsPrinter Friendly Version
03/12/15Depomed Secures $575 Million Debt Facility From Deerfield and Pharmakon to Finance the Closing of NUCYNTA® AcquisitionPrinter Friendly Version
03/03/15Depomed To Present At 27th Annual Roth ConferencePrinter Friendly Version
02/23/15Depomed Reports Fourth Quarter and Full Year 2014 Financial ResultsPrinter Friendly Version
02/12/15Depomed To Report Fourth Quarter Fiscal Year 2014 Financial Results On Monday, February 23, 2015Printer Friendly Version
02/09/15New American Headache Society Assessment of Acute Migraine Treatments Highlights Effective Therapies Based on Strength of EvidencePrinter Friendly Version
02/04/15Depomed To Present At Healthcare Conferences In FebruaryPrinter Friendly Version
01/15/15Depomed to Acquire U.S. Rights to NUCYNTA® (tapentadol), NUCYNTA® ER (tapentadol) extended release tablets and NUCYNTA® (tapentadol) Oral Solution from Janssen Pharmaceuticals, Inc. for $1.05 billionPrinter Friendly Version

DEPO (Common Stock)

Exchange
NASDAQ CM
Price
$20.59
Change (%)
 - 0.17 (0.82%)
Volume
1,166,087
Market Cap
$1,234,638,170

Data as of 05/26/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Powered By EDGAR Online, Inc.